rs61752893
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP6_Very_StrongBS1
The NM_000329.3(RPE65):c.644-42del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000262 in 1,522,372 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★★).
Frequency
Genomes: 𝑓 0.00040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )
Consequence
RPE65
NM_000329.3 intron
NM_000329.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -2.55
Genes affected
RPE65 (HGNC:10294): (retinoid isomerohydrolase RPE65) The protein encoded by this gene is a component of the vitamin A visual cycle of the retina which supplies the 11-cis retinal chromophore of the photoreceptors opsin visual pigments. It is a member of the carotenoid cleavage oxygenase superfamily. All members of this superfamily are non-heme iron oxygenases with a seven-bladed propeller fold and oxidatively cleave carotenoid carbon:carbon double bonds. However, the protein encoded by this gene has acquired a divergent function that involves the concerted O-alkyl ester cleavage of its all-trans retinyl ester substrate and all-trans to 11-cis double bond isomerization of the retinyl moiety. As such, it performs the essential enzymatic isomerization step in the synthesis of 11-cis retinal. Mutations in this gene are associated with early-onset severe blinding disorders such as Leber congenital. [provided by RefSeq, Oct 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
BP6
?
Variant 1-68439683-TA-T is Benign according to our data. Variant chr1-68439683-TA-T is described in ClinVar as [Likely_benign]. Clinvar id is 98885.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr1-68439683-TA-T is described in Lovd as [Likely_benign].
BS1
?
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000247 (338/1370198) while in subpopulation MID AF= 0.0106 (59/5584). AF 95% confidence interval is 0.00841. There are 0 homozygotes in gnomad4_exome. There are 155 alleles in male gnomad4_exome subpopulation. Median coverage is 20. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPE65 | NM_000329.3 | c.644-42del | intron_variant | ENST00000262340.6 | |||
LOC124904198 | XR_007066164.1 | n.72-8848del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPE65 | ENST00000262340.6 | c.644-42del | intron_variant | 1 | NM_000329.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000401 AC: 61AN: 152056Hom.: 0 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
61
AN:
152056
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000317 AC: 79AN: 249042Hom.: 0 AF XY: 0.000237 AC XY: 32AN XY: 134804
GnomAD3 exomes
AF:
AC:
79
AN:
249042
Hom.:
AF XY:
AC XY:
32
AN XY:
134804
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000247 AC: 338AN: 1370198Hom.: 0 Cov.: 20 AF XY: 0.000226 AC XY: 155AN XY: 687092
GnomAD4 exome
AF:
AC:
338
AN:
1370198
Hom.:
Cov.:
20
AF XY:
AC XY:
155
AN XY:
687092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000401 AC: 61AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74418
GnomAD4 genome
?
AF:
AC:
61
AN:
152174
Hom.:
Cov.:
32
AF XY:
AC XY:
30
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2Other:1
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
RPE65-related recessive retinopathy Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen | Apr 22, 2024 | The c.644-42del variant in RPE65, is an intronic variant which is present outside of consensus splice sites. The splicing impact predictor SpliceAI gives a delta score of 0.09, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4, BP7). In addition, the PhyloP score was -2.63 which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1, which depicts that the nucleotide is not highly conserved. This intronic variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.000827, with 26/24712 in the African/ African-American population, which is higher than the ClinGen LCA / eoRD VCEP BS1 threshold of >0.0008 (BS1). In summary this variant meets criteria to be classified as Likely Benign for Leber congenital amaurosis (RPE65) based on the ACMG/AMP criteria (codes met: BP4, BP7, BS1). (VCEP specifications version 1.0.0; date of approval 09/21/2023). - |
Leber congenital amaurosis 2;C3151086:Retinitis pigmentosa 20 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Counsyl | Nov 20, 2017 | - - |
not provided Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at